Paper17515897
Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
Mullican SE and 6 others. Nat Med, 2007. Cited by 278 papers, by iCite.
Cite this record
ConductScience Library. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Papers, record 17515897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17515897
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Leukemia, Myeloid | Major topic |
| Nerve Tissue Proteins | Major topic |
| Receptors, Cytoplasmic and Nuclear | Major topic |
| Receptors, Steroid | Major topic |
| Receptors, Thyroid Hormone | Major topic |
| Transcription Factors | Major topic |
| Acute Disease | |
| Animals | |
| Blast Crisis | |
| Down-Regulation | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Nuclear Receptor Subfamily 4, Group A, Member 1 |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA111411 | NCI NIH HHS | United States | R01CA111411 | PubMed and NIH | NIH RePORTER |
| CA16672 | NCI NIH HHS | United States | P01CA016672 | PubMed and NIH | NIH RePORTER |
| P01CA55164 | NCI NIH HHS | United States | P01CA055164 | PubMed and NIH | NIH RePORTER |
| U19DK62434 | NIDDK NIH HHS | United States | U19DK062434 | PubMed and NIH | NIH RePORTER |
| P30CA016672 | NIH | NIH RePORTER |
Cited by194
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 278 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42533114 | PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy. | Oncogene | 2026 | https://conductscience.org/library/papers/42533114 | PubMed |
| 42254657 | Integrated transcriptomic identification and validation reveal key autophagy-associated biomarkers in sleep deprivation. | PeerJ | 2026 | https://conductscience.org/library/papers/42254657 | PubMed |
| 41666265 | Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia. | Sci Signal | 2026 | https://conductscience.org/library/papers/41666265 | PubMed |
| 41534998 | Functional roles of NR4A transcription factors in GnRH regulation of gonadotropin gene expression and secretion in rat primary pituitary cells. | J Reprod Dev | 2026 | https://conductscience.org/library/papers/41534998 | PubMed |
| 41419000 | Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice. | Am J Physiol Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41419000 | PubMed |
| 41237238 | Blocking nuclear receptor Nr4a3 unlocks the senescence barrier to promote direct cardiac reprogramming. | Sci Adv | 2025 | https://conductscience.org/library/papers/41237238 | PubMed |
| 41107372 | NR4A1 expression aberrations contribute to radiotherapy resistance in gastric cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41107372 | PubMed |
| 40666103 | Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance. | Front Oncol | 2025 | https://conductscience.org/library/papers/40666103 | PubMed |
| 40508074 | Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508074 | PubMed |
| 40332813 | Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40332813 | PubMed |
| 40114913 | Nuclear receptor 4A1 is critical for neutrophil-dependent pulmonary immunity to Klebsiella pneumoniae infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/40114913 | PubMed |
| 40079203 | Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology. | FASEB J | 2025 | https://conductscience.org/library/papers/40079203 | PubMed |
| 40028473 | Investigation methylation status of tumor suppressor gene NR4A1 and NR4A3 and frequency of rs1569686 polymorphism of DNMT3B gene in patients with acute myeloid leukemia. | Mol Biol Res Commun | 2025 | https://conductscience.org/library/papers/40028473 | PubMed |
| 39872303 | Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy. | Life Med | 2023 | https://conductscience.org/library/papers/39872303 | PubMed |
| 39840064 | NR2F6 regulates stem cell hematopoiesis and myelopoiesis in mice. | Front Immunol | 2024 | https://conductscience.org/library/papers/39840064 | PubMed |
| 39824797 | Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice. | Nat Commun | 2025 | https://conductscience.org/library/papers/39824797 | PubMed |
| 39589268 | NR4A1 and NR4A2 orphan nuclear receptors regulate endothelial-to-hematopoietic transition in mouse hematopoietic stem cell specification. | Development | 2024 | https://conductscience.org/library/papers/39589268 | PubMed |
| 39422036 | Orphan nuclear receptor NR4A1 regulates both osteoblastogenesis and adipogenesis in human mesenchymal stem cells. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/39422036 | PubMed |
| 39417168 | A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonists. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39417168 | PubMed |
| 39219449 | Loss of glucose-stimulated β-cell Nr4a1 expression impairs insulin secretion and glucose homeostasis. | Am J Physiol Cell Physiol | 2024 | https://conductscience.org/library/papers/39219449 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
| NR4A3 | 8013 | PubTator's text mining | https://conductscience.org/library/genes/8013 | NCBI Gene |
| TNFSF10 | 8743 | PubTator's text mining | https://conductscience.org/library/genes/8743 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17515897
GET https://conductscience.org/api/papers/v1/17515897/cited_by?page=2